PHAR300 Pharmacotherapy I Exam Prep – Real Practice Questions,
Answers & Detailed Rationales (Updated 2026) |
Pharmacokinetics & Pharmacodynamics, Drug Therapy Management,
Cardiovascular & Respiratory Medications, Antibiotics & Antimicrobial
Therapy, Endocrine & Gastrointestinal Pharmacotherapy, Adverse Drug
Reactions, Clinical Case Studies, Medication Safety & Therapeutic Care
Planning
Question 1: Which of the following best describes the primary goal of
pharmacotherapy?
A. To diagnose diseases based on symptomatology
B. To eliminate all microorganisms from the body
C. To restore or maintain health through the use of medications
D. To replace surgical interventions whenever possible
CORRECT ANSWER: C. To restore or maintain health through the use of
medications
Rationale: Pharmacotherapy involves the treatment of diseases or conditions using
pharmaceutical drugs with the aim of restoring, maintaining, or promoting health. It is
not primarily diagnostic, antimicrobial in all cases, nor intended to universally replace
surgery.
Question 2: What does the term "therapeutic index" refer to in pharmacology?
A. The ratio of a drug’s cost to its clinical benefit
B. The dose at which a drug begins to show adverse effects
C. The ratio of the toxic dose to the therapeutic dose of a drug
D. The time required for a drug to reach peak plasma concentration
CORRECT ANSWER: C. The ratio of the toxic dose to the therapeutic dose of a drug
Rationale: The therapeutic index (TI) quantifies the safety margin of a drug and is
calculated as the ratio of the dose that produces toxicity (TD50) to the dose that
produces a therapeutic effect (ED50). A higher TI indicates a safer drug.
Question 3: Which pharmacokinetic process describes the movement of a drug
from its site of administration into the bloodstream?
A. Metabolism
B. Distribution
C. Absorption
D. Excretion
CORRECT ANSWER: C. Absorption
Rationale: Absorption is the process by which a drug enters systemic circulation from
its site of administration (e.g., gastrointestinal tract, skin, muscle). Distribution,
metabolism, and excretion occur after absorption.
,Question 4: Which route of drug administration typically provides the fastest onset
of action?
A. Oral
B. Intravenous
C. Transdermal
D. Subcutaneous
CORRECT ANSWER: B. Intravenous
Rationale: Intravenous (IV) administration delivers the drug directly into the
bloodstream, bypassing absorption barriers and providing immediate onset of action,
unlike other routes that require absorption time.
Question 5: First-pass metabolism primarily affects drugs administered via which
route?
A. Intramuscular
B. Sublingual
C. Oral
D. Inhalation
CORRECT ANSWER: C. Oral
Rationale: Orally administered drugs pass through the portal circulation to the liver
before reaching systemic circulation, where they may undergo significant metabolism
(first-pass effect), reducing bioavailability.
Question 6: Which of the following is a characteristic of a competitive antagonist?
A. It irreversibly binds to the receptor
B. It activates the receptor partially
C. Its effects can be overcome by increasing agonist concentration
D. It decreases the maximum efficacy of the agonist
CORRECT ANSWER: C. Its effects can be overcome by increasing agonist
concentration
Rationale: Competitive antagonists bind reversibly to the same site as the agonist; thus,
their inhibitory effect can be surmounted by increasing the concentration of the agonist,
preserving maximal response.
Question 7: Which enzyme system is primarily responsible for phase I drug
metabolism in the liver?
A. UDP-glucuronosyltransferase
B. Cytochrome P450
C. Glutathione S-transferase
D. N-acetyltransferase
CORRECT ANSWER: B. Cytochrome P450
, Rationale: The cytochrome P450 (CYP450) enzyme family catalyzes oxidation,
reduction, and hydrolysis reactions in phase I metabolism, making drugs more polar for
subsequent conjugation or excretion.
Question 8: What is the primary purpose of therapeutic drug monitoring (TDM)?
A. To confirm patient adherence to non-pharmacological therapies
B. To measure drug concentrations to optimize efficacy and minimize toxicity
C. To determine the genetic profile of a patient
D. To replace clinical assessment of drug response
CORRECT ANSWER: B. To measure drug concentrations to optimize efficacy and
minimize toxicity
Rationale: TDM is used for drugs with narrow therapeutic windows (e.g., digoxin,
phenytoin) to ensure plasma levels are within a range that maximizes benefit while
avoiding adverse effects.
Question 9: Which of the following drugs exhibits zero-order kinetics at therapeutic
doses?
A. Acetaminophen
B. Penicillin
C. Ethanol
D. Metoprolol
CORRECT ANSWER: C. Ethanol
Rationale: Ethanol is metabolized by alcohol dehydrogenase, which becomes saturated
at relatively low concentrations, leading to zero-order kinetics—constant amount
metabolized per unit time, regardless of concentration.
Question 10: What does bioavailability refer to in pharmacokinetics?
A. The rate at which a drug is excreted
B. The fraction of an administered dose that reaches systemic circulation unchanged
C. The volume of distribution of a drug
D. The half-life of a drug in plasma
CORRECT ANSWER: B. The fraction of an administered dose that reaches systemic
circulation unchanged
Rationale: Bioavailability quantifies the proportion of a drug dose that enters systemic
circulation in its active form. IV drugs have 100% bioavailability; other routes may have
less due to incomplete absorption or first-pass metabolism.
Question 11: Which of the following best defines drug tolerance?
A. An immune-mediated reaction to a drug
B. A decreased response to a drug after repeated administration
Answers & Detailed Rationales (Updated 2026) |
Pharmacokinetics & Pharmacodynamics, Drug Therapy Management,
Cardiovascular & Respiratory Medications, Antibiotics & Antimicrobial
Therapy, Endocrine & Gastrointestinal Pharmacotherapy, Adverse Drug
Reactions, Clinical Case Studies, Medication Safety & Therapeutic Care
Planning
Question 1: Which of the following best describes the primary goal of
pharmacotherapy?
A. To diagnose diseases based on symptomatology
B. To eliminate all microorganisms from the body
C. To restore or maintain health through the use of medications
D. To replace surgical interventions whenever possible
CORRECT ANSWER: C. To restore or maintain health through the use of
medications
Rationale: Pharmacotherapy involves the treatment of diseases or conditions using
pharmaceutical drugs with the aim of restoring, maintaining, or promoting health. It is
not primarily diagnostic, antimicrobial in all cases, nor intended to universally replace
surgery.
Question 2: What does the term "therapeutic index" refer to in pharmacology?
A. The ratio of a drug’s cost to its clinical benefit
B. The dose at which a drug begins to show adverse effects
C. The ratio of the toxic dose to the therapeutic dose of a drug
D. The time required for a drug to reach peak plasma concentration
CORRECT ANSWER: C. The ratio of the toxic dose to the therapeutic dose of a drug
Rationale: The therapeutic index (TI) quantifies the safety margin of a drug and is
calculated as the ratio of the dose that produces toxicity (TD50) to the dose that
produces a therapeutic effect (ED50). A higher TI indicates a safer drug.
Question 3: Which pharmacokinetic process describes the movement of a drug
from its site of administration into the bloodstream?
A. Metabolism
B. Distribution
C. Absorption
D. Excretion
CORRECT ANSWER: C. Absorption
Rationale: Absorption is the process by which a drug enters systemic circulation from
its site of administration (e.g., gastrointestinal tract, skin, muscle). Distribution,
metabolism, and excretion occur after absorption.
,Question 4: Which route of drug administration typically provides the fastest onset
of action?
A. Oral
B. Intravenous
C. Transdermal
D. Subcutaneous
CORRECT ANSWER: B. Intravenous
Rationale: Intravenous (IV) administration delivers the drug directly into the
bloodstream, bypassing absorption barriers and providing immediate onset of action,
unlike other routes that require absorption time.
Question 5: First-pass metabolism primarily affects drugs administered via which
route?
A. Intramuscular
B. Sublingual
C. Oral
D. Inhalation
CORRECT ANSWER: C. Oral
Rationale: Orally administered drugs pass through the portal circulation to the liver
before reaching systemic circulation, where they may undergo significant metabolism
(first-pass effect), reducing bioavailability.
Question 6: Which of the following is a characteristic of a competitive antagonist?
A. It irreversibly binds to the receptor
B. It activates the receptor partially
C. Its effects can be overcome by increasing agonist concentration
D. It decreases the maximum efficacy of the agonist
CORRECT ANSWER: C. Its effects can be overcome by increasing agonist
concentration
Rationale: Competitive antagonists bind reversibly to the same site as the agonist; thus,
their inhibitory effect can be surmounted by increasing the concentration of the agonist,
preserving maximal response.
Question 7: Which enzyme system is primarily responsible for phase I drug
metabolism in the liver?
A. UDP-glucuronosyltransferase
B. Cytochrome P450
C. Glutathione S-transferase
D. N-acetyltransferase
CORRECT ANSWER: B. Cytochrome P450
, Rationale: The cytochrome P450 (CYP450) enzyme family catalyzes oxidation,
reduction, and hydrolysis reactions in phase I metabolism, making drugs more polar for
subsequent conjugation or excretion.
Question 8: What is the primary purpose of therapeutic drug monitoring (TDM)?
A. To confirm patient adherence to non-pharmacological therapies
B. To measure drug concentrations to optimize efficacy and minimize toxicity
C. To determine the genetic profile of a patient
D. To replace clinical assessment of drug response
CORRECT ANSWER: B. To measure drug concentrations to optimize efficacy and
minimize toxicity
Rationale: TDM is used for drugs with narrow therapeutic windows (e.g., digoxin,
phenytoin) to ensure plasma levels are within a range that maximizes benefit while
avoiding adverse effects.
Question 9: Which of the following drugs exhibits zero-order kinetics at therapeutic
doses?
A. Acetaminophen
B. Penicillin
C. Ethanol
D. Metoprolol
CORRECT ANSWER: C. Ethanol
Rationale: Ethanol is metabolized by alcohol dehydrogenase, which becomes saturated
at relatively low concentrations, leading to zero-order kinetics—constant amount
metabolized per unit time, regardless of concentration.
Question 10: What does bioavailability refer to in pharmacokinetics?
A. The rate at which a drug is excreted
B. The fraction of an administered dose that reaches systemic circulation unchanged
C. The volume of distribution of a drug
D. The half-life of a drug in plasma
CORRECT ANSWER: B. The fraction of an administered dose that reaches systemic
circulation unchanged
Rationale: Bioavailability quantifies the proportion of a drug dose that enters systemic
circulation in its active form. IV drugs have 100% bioavailability; other routes may have
less due to incomplete absorption or first-pass metabolism.
Question 11: Which of the following best defines drug tolerance?
A. An immune-mediated reaction to a drug
B. A decreased response to a drug after repeated administration
